Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
The Scientific Evidence Ozempic, known generically as semaglutide, is primarily FDA-approved for the treatment of type 2 diabetes and the reduction of cardiovascular risk in adults with known heart disease
Endocrinology 152 , 618628 (2011)
This matters for our region too: dementia prevalence in Arab countries ranges between 1.1% and 2.3% among those 50+, climbing to 13.518.5% among those 80 and older (PubMed Central) and as Gulf healthcare systems push toward home-care models and reduced hospital burden, this kind of label change is exactly the type of precedent local regulators (SFDA, MoPH, NHRA) will be watching: how do you extend access to complex biologics without compromising safety oversight
CNS Neurol Disord - Drug Targets 13:10961119
